Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04260802 |
| Title | A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Ocellaris Pharma, Inc. |
| Indications |
triple-receptor negative breast cancer |
| Therapies |
OC-001 + unspecified PD-L1 antibody |
| Age Groups: | senior | adult |
| Covered Countries | CAN |
CKB BOOST